CLINICAL_TRIALS
trial_result
· 2024-02-08
Clinical Trial Update: Varenicline Treatment in Alcohol and Nicotine Dependent Patients With Schizophrenia [Phase 4]
Summary
Phase 4 clinical trial evaluating varenicline for individuals with schizophrenia or schizoaffective disorder who are also dependent on alcohol and nicotine.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: State University of New York - Upstate Medical University | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED